Since 1954, patients have been prescribed warfarin, a blood thinning drug that is designed to prevent strokes and other cardiovascular issues. The drug, also known as Coumadin, has been taken by more than two million Americans. In 2011, the U.S. Food and Drug Administration approved the use of Coumadin’s competitor, Xarelto. The goal of the two drugs is largely similar. Unfortunately, however, the use of Xarelto has been associated with severe injury and even death. Unlike with patients who have taken Coumadin, numerous lawsuits have arisen as a result.
4 Factors That Separate Xarelto From Warfarin
What makes Xarelto different from Coumadin? The following are four examples:
- The two drugs work differently. Warfarin is designed to make the blood less likely to clot by blocking the body’s ability to recycle vitamin K. Vitamin K is used by the body to form clots. When there is less of the vitamin in circulation throughout the body, the blood takes longer to clot.
- The availability of a reversal agent is different. While both drugs carry the risk of hemorrhaging, which can be lethal, only warfarin has a known reversal agent. The effects of warfarin can be countered by taking vitamin K.
- The dosage needed for the two drugs is different. To reduce the risk of a stroke, the typical dose of Xarelto is 20 milligrams once per day. For warfarin, however, the dosage varies between individuals. It is typically determined based upon a person’s age, diet, and use of other medications.
- The cost is different. Xarelto tends to be more expensive than warfarin for patients who do not have insurance. When the drug is covered, however, the cost becomes more comparable.
In pursuing legal action against the manufacturer of Xarelto, many patients accuse the drug maker of fraudulent misrepresentation. If you were injured after taking this medication, you may have a claim for compensation. We encourage you to reach out today for a free consultation at 855-947-0707.